Controversies in the use of beta-agonists in the treatment of acute asthma;Controversias sobre el uso de los agonistas beta en el tratamiento del asma aguda

Archivos de Bronconeumologia

Volumn 38, Issue 7, 2002, Pages 322-328

  Rodrigo, G J ^a   Rodrigo, C ^b  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b Department of Cardiology   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ACUTE DISEASE; ASTHMA; COMPARATIVE STUDY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METERED DOSE INHALER; METHODOLOGY; NEBULIZER; REVIEW; CLINICAL PRACTICE; DOSE CALCULATION; NEBULIZATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ASTHMA; HUMANS; INJECTIONS, INTRAVENOUS; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS;

EID: 0036628616     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(02)75226-5     Document Type: Review

References (80)

1. British guidelines on asthma management, 1995 review and position statement
2. Where have we been? The history of acute asthma
3. National and international guidelines for the emergency management of adult asthma in North American emergency departments
4. The use of systemic beta-agonists in acute asthma in North American emergency departments
5. Intravenous beta2-agonists for acute asthma in the emergency department
6. Randomized trial of intravenous albuterol in early management of acute severe asthma in children
7. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children
8. Continuous vs intermittent nebulized albuterol for emergency management of asthma
9. Continuous nebulization of albuterol (Salbutamol) in acute asthma
10. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma
11. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department
12. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: A randomized, prospective study
13. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe asthma in adults
14. Continuous versus intermittent nebulization of Salbutamol in acute severe asthma. A randomized, controlled trial
15. State of the art: Therapeutic controversies in severe acute asthma
16. Fármacos betaagonistas en el tratamiento del asma bronquial
17. Spacer devices used with meter-dose inhalers: Breakthrough or gimmick?
18. Site of beta-adrenergics receptors in the respiratory tract: Use of fenoterol administered by two methods
19. Patterns of deposition of labeled monodispersed aerosols in obstructive lung disease
20. Aerosol characterization and deposition
21. Deposition of aerosol in the respiratory tract
22. Optimal delivery of aerosols from metered dose inhalers
23. An evaluation of the physical properties of monodisperse and heterodisperse aerosols used in the assessment of bronchial function
24. Assessment of jet nebulizers for lung aerosol therapy
25. Factors influencing the size distribution of aerosols from jet nebulizers
26. In vivo measurements of aerosol dose and distribution: Clinical relevance
27. Targets for inhaled treatment
28. Deposition of pressurized aerosols in the human respiratory tract
29. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols
30. Aerosol deposition considerations in inhalation therapy
31. Current concepts: Control of asthma by aerosols
32. Disposable jet nebulizers. How reliable are they?
33. A comparison of commercial jet nebulizers
34. Medication nebulizer performance: Effects of diluent volume, nebulizer flow, and nebulizer brand
35. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung
36. Comparison of nebulized aerosol deposition in the lungs of healthy adults following oral and nasal inhalation
37. Therapeutic aerosols 1. Physical and practical considerations
38. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients
39. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large acute-care hospital
40. In vitro performance of plastic spacer devices
41. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the nebuhaler
42. Inhalation therapy in asthma: Nebulizer or pressurized meter-dosc inhaler with holding chamber? In vivo comparison of lung deposition in children
43. Bronchodilator delivery in acute airflow obstruction. A meta-analysis
44. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma
45. Comparison of salbutamol delivered by nebulizer or metereddose inhaler with a pear-shaped spacer in acute asthma
46. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer
47. Asthma therapy with aerosols: Are nebulizers obsolete? A continuing controversy
48. Consensus statement: Aerosols and delivery devices
49. Tratamiento de la crisis asmática: Comparación entre fenoterol y Salbutamol en altas dosis administradas mediante inhalador de dosis medida con inhalocámara y aminofilina intravenosa
50. Assessment of the patient with acute asthma in the emergency department: A factor analytic study
51. A new indez for early prediction of hospitalization in patients with acute asthma
52. Early prediction of poor response acute asthma patients in the emergency department
53. Inhaled beta-agonists and acute asthma
54. Optimal close of Salbutamol respiratory solution: Comparison of three doses with plasma levels
55. Betaadrenoceptor responses to high doses of inhaled Salbutamol in patients with bronchial asthma
56. High doses of sympathomimetics in severe bronchial asthma
57. Comparison of cumulative and noncumulative techniques to measure dose-response curves for beta-agonists in patients with asthma
58. Metered dose inhaler Salbutamol treatment of asthma in the ED: Comparison of two doses with plasma levels
59. Observations on the effects of aerosolizcd albuterol in acute asthma
60. Therapeutic response pattern to high and cumulative doses of Salbutamol in acute severe asthma
61. Comparison of two dosage regimen of albuterol in acute asthma
62. 2 agonists for treating acute childhood and adolescent asthma? A systematic review
63. Ipratropium bromide in acute adult severe asthma: A meta-analysis of randomized controlled trials
64. First-line therapy for adults acute asthma patients with a multiple dose protocol of ipratropium bromide plus albuterol on the emergency department
65. Inhaled flunisolide for acute severe asthma
66. S-albuterol exacerbates calcium responses to carbacol in airway smooth muscle cells
67. Stereoselective metabolism of RS-albuterol in humans
68. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma
69. Bronchodilating effects and side effects of beta-adrenoreceptor stimulants by different modes of administration
70. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: Influence of mouth rinsing and gargling
71. Efficacy and safety of a rapid-sequence metaproterenol protocol in the treatment of acute adult asthma
72. Arterial oxygen desaturation following salbutamol inhalation in acute asthma
73. Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization
74. Acute severe asthma: Pathophysiology and pathobiology of gas exchange abnormalities
75. 2-receptor stimulation by circulating epinephrine
76. Hypokalemia and other nonbronchial effects of inhaled fenoterol and Salbutamol: A placebo controlled dose-response study in healthy volunteers
77. Cardiovascular and hypokalaemic effects of inhaled Salbutamol fenoterol and isoprenaline
78. High serum albuterol levels and tachycardia in adult ashtmatics treated with high-dose continuously aerosolized albuterol
79. High versus low-dose, frequently administered nebulized albuterol in children with severe acute asthma